Powered Prosthetic Knee for Below Knee Amputation
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to determine if a powered microprocessor-controlled knee (PMPK) can improve walking ease and efficiency for individuals with above-knee amputations. The trial will compare the PMPK with the prosthetic knee currently used by participants. Eligible participants must have one leg amputated above the knee, use a prosthesis daily without issues, and be comfortable walking at various speeds. As an unphased trial, this study provides participants the opportunity to contribute to innovative research that could enhance mobility solutions.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that this powered microprocessor-controlled knee is safe for below knee amputation?
Research shows that microprocessor-controlled prosthetic knees (MPKs) are generally safe and can aid people with above-knee amputations by enhancing safety, stability, and movement. Studies have found that these knees may reduce the risk of falls and improve balance, which is crucial for daily activities. However, there isn't enough evidence yet to confirm they significantly enhance overall health.
The powered microprocessor-controlled knee (PMPK) under study is already available for purchase, indicating it has passed some safety checks. Although limited safety information exists for below-knee amputations, MPKs are considered essential for some amputees, reflecting trust in their safety and benefits. Overall, while more research is needed, current evidence suggests that PMPKs are generally well-accepted.12345Why are researchers excited about this trial?
Researchers are excited about the Powered Microprocessor-controlled Knee (PMPK) because it offers a dynamic and adaptive approach to prosthetic knees for below-knee amputation. Unlike traditional prosthetic knees that rely on passive mechanisms, the PMPK actively powers movement, mimicking natural knee function more closely. This smart technology adjusts in real-time to changes in walking speed and terrain, providing users with improved stability and mobility. By enhancing the user's gait and reducing effort, the PMPK has the potential to significantly improve quality of life for amputees compared to existing prosthetic options.
What evidence suggests that this powered microprocessor-controlled knee is effective for improving metabolic function during walking?
Research shows that microprocessor-controlled prosthetic knees (MPKs) can make life safer and easier for people with above-knee amputations. Studies have found that these knees help users walk on various surfaces, improving mobility. They also reduce the risk of falls, a major concern for many prosthetic users. While results can vary, evidence suggests that MPKs outperform prosthetic knees without microprocessors. This trial will specifically evaluate the effectiveness of the Powered Microprocessor-Controlled Knee (PMPK) for individuals with below-knee amputations, as the benefits for this group remain unclear and require further research.12467
Who Is on the Research Team?
Michael Davidson, Ph.D.
Principal Investigator
Loma Linda University Health
Are You a Good Fit for This Trial?
This trial is for men and women aged 18-75 who have lost one leg above the knee, weigh between 49-117 kg, walk or play sports with a prosthesis daily, and have been doing so for at least six months without recent socket issues or limb pain that affects function.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Initial Visit
Informed consent, HIPAA authorization, ambulation potential verification, body measurements, balance confidence scale, posture alignment assessment
Second Visit
Fit with heart rate monitor and metabolic analyzer, treadmill tests, posture alignment assessment, use PMPK for one week
Third Visit
Fit with heart rate monitor and metabolic analyzer, treadmill tests, balance confidence scale, return PMPK, verify alignment
Follow-up
Participants are monitored for safety and effectiveness after treatment
What Are the Treatments Tested in This Trial?
Interventions
- PMPK
PMPK is already approved in European Union, United States, Canada for the following indications:
- Lower limb loss
- Mobility assistance
- Lower limb loss
- Mobility assistance
- Lower limb loss
- Mobility assistance
Find a Clinic Near You
Who Is Running the Clinical Trial?
Loma Linda University
Lead Sponsor
Össur Ehf
Industry Sponsor
Össur Iceland ehf
Industry Sponsor